Literature DB >> 24268611

Statins: new American guidelines for prevention of cardiovascular disease.

Paul M Ridker1, Nancy R Cook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24268611     DOI： 10.1016/S0140-6736(13)62388-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  160 in total

1.  Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Michael J Blaha; Miguel Cainzos-Achirica; Philip Greenland; John W McEvoy; Ron Blankstein; Matthew J Budoff; Zeina Dardari; Christopher T Sibley; Gregory L Burke; Richard A Kronmal; Moyses Szklo; Roger S Blumenthal; Khurram Nasir
Journal:  Circulation       Date:  2016-01-22       Impact factor: 29.690

2.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  The new cholesterol and blood pressure guidelines: perspective on the path forward.

Authors:  Harlan M Krumholz
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

4.  Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.

Authors:  Samia Mora; Nanette K Wenger; Nancy R Cook; Jingmin Liu; Barbara V Howard; Marian C Limacher; Simin Liu; Karen L Margolis; Lisa W Martin; Nina P Paynter; Paul M Ridker; Jennifer G Robinson; Jacques E Rossouw; Monika M Safford; JoAnn E Manson
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

5.  [New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Authors:  G Klose; F U Beil; H Dieplinger; A von Eckardstein; B Föger; I Gouni-Berthold; W Koenig; G M Kostner; U Landmesser; U Laufs; F Leistikow; W März; M Merkel; D Müller-Wieland; G Noll; K G Parhofer; B Paulweber; W Riesen; J R Schaefer; E Steinhagen-Thiessen; A Steinmetz; H Toplak; C Wanner; E Windler
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

Review 6.  Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.

Authors:  Nivee P Amin; Seth S Martin; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Erin D Michos
Journal:  J Am Coll Cardiol       Date:  2014-05-07       Impact factor: 24.094

Review 7.  Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

Authors:  Ian M Graham; Alberico L Catapano
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 8.  Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.

Authors:  Morton Leibowitz; Chandra Cohen-Stavi; Sanjay Basu; Ran D Balicer
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 9.  Biomarkers of cardiovascular disease risk in women.

Authors:  JoAnn E Manson; Shari S Bassuk
Journal:  Metabolism       Date:  2014-10-30       Impact factor: 8.694

10.  Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics.

Authors:  Gregory A Phelps; Yanru Qiao; Merrion G Buckley; Junling Wang; Minghui Sam Li; Soumitra S Bhuyan; Marie A Chisholm-Burns
Journal:  Res Social Adm Pharm       Date:  2019-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.